Eton Pharmaceuticals, Inc. (ETON) — Stock Score Summary

Eton Pharmaceuticals, Inc. (ETON) has a MoatMap StockRank of 58/100 based on Quality (49/100), Value (14/100), and Momentum (80/100) factor scores. The current signal is HOLD. Eton is a micro-cap specialty pharmaceutical company that does not possess the scale, high ROIC, or CDMO pricing power required to fit our quality compounder framework.

Eton Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative products for rare diseases and other high-unmet-need indications. The company primarily utilizes the 505(b)(2) regulatory pathway to efficiently bring differentiated drug formulations to market, often addressing pediatric or critical care settings. It operates as a nimble pharmaceutical firm, strategically targeting niche markets with its portfolio of neurology, cardiology, and rare disease products.

Key Financial Metrics

Price$29.02
Market Cap$873M
P/E (Forward)15.37
Price/Book25.83
Return on Equity-5.4%
Return on Invested Capital-1.6%
Debt/Equity102.11
Gross Margin59.7%
Operating Margin11.4%
Revenue Growth40.4%
Free Cash Flow$2M

Eton Pharmaceuticals, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Eton Pharmaceuticals, Inc.’s (ETON) StockRank?
MoatMap’s StockRank for Eton Pharmaceuticals, Inc. (ETON) is 58/100, with a Hold signal. It is a composite of Quality (49), Value (14), and Momentum (80) factor ranks across MoatMap’s 19,000+ stock universe.
Does Eton Pharmaceuticals, Inc. have an economic moat?
Eton Pharmaceuticals, Inc. (ETON) has a Quality factor score of 49/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Eton Pharmaceuticals, Inc. a buy, hold, or sell?
MoatMap’s current signal for Eton Pharmaceuticals, Inc. (ETON) is Hold, based on a StockRank of 58/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Eton Pharmaceuticals, Inc. in?
Eton Pharmaceuticals, Inc. (ETON) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (United States).
Browse all ranked stocksETON deep dive reportAI ChampionsHow we score stocksSense-check another stock